Analysis ImmuPharma PLC (IMM)
5/30/2024
Analysis of ImmuPharma PLC (IMM)
ImmuPharma PLC (IMM) has shown some volatility in its stock price recently. The Relative Strength Index (RSI) values have been fluctuating around the 50 mark, indicating a balanced market sentiment between buying and selling pressure.The Moving Average Convergence Divergence (MACD) indicator has been hovering around the zero line, suggesting a lack of strong trend in the stock price movement. The MACD histogram has been mostly negative, indicating some bearish momentum.
The stock price has been trading around the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values, with some fluctuations above and below these levels.
Overall, based on the RSI, MACD, and moving averages, it seems that ImmuPharma PLC is currently experiencing a period of consolidation and uncertainty in its stock price movement. Traders and investors may need to closely monitor the price action for potential breakout or reversal signals.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. The current year growth rate is estimated to be 7.5%.
2. The next quarter growth rate is expected to be 4.8%.
3. The current quarter growth rate is projected to be 5.6%.
4. The next year growth rate is forecasted to be 9.7%.
5. The average annual growth rate for the next 5 years is estimated to be 11%.
6. The average annual growth rate for the past 5 years was approximately 20.1%.
These estimates suggest that the company is expected to experience moderate growth in the short term, with a slightly higher growth rate projected for the next year. However, the company's growth is expected to accelerate over the next 5 years compared to the past 5 years.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions regarding the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price of the security is $191.57, which is below the median and average forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were related to the transfer agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31%, with a fiscal year ending on September 30, 2023. The income statement reveals an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, with 15.31 billion float shares and 99.29 million shares shorted. The stock outstanding is 15.33 billion, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and price to sales ratio of 7.65.
The stock price summary includes a beta of 1.26, 50-day moving average of $176.26, and 200-day moving average of $181.04. The 52-week low and high are $164.08 and $199.62 respectively, with a 52-week change of 6.85%.
Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date on May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a significant increase in revenue from FY 2020 to FY 2022, followed by a slight decrease in FY 2023.
- Overall, there has been a positive revenue growth trend over the past four years, indicating the company's ability to generate increasing sales.
- It is important to further analyze the reasons behind the fluctuations in revenue to understand the company's performance and market dynamics.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2022 at $217,350,000,000.
4. Total liabilities have also been increasing, reaching $290,437,000,000 in 2023.
5. Shareholders' equity has shown variations, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its operations.
7. There is a significant amount of debt in the company's capital structure, both short-term and long-term.
8. Retained earnings have been negative in some years, indicating losses or dividend payouts exceeding profits.
9. The company has been investing in leases, machinery, furniture, and equipment to support its operations.
10. Overall, the company's financial position seems stable, but it needs to manage its debt levels and improve its profitability.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, with a low estimate of $1.27 and a high estimate of $1.36. This shows growth compared to the EPS of $1.26 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, with a low estimate of $1.44 and a high estimate of $1.63. This indicates an increase from the EPS of $1.46 from the same quarter last year.
3. For the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, with a low estimate of $6.43 and a high estimate of $6.92. This reflects growth compared to the EPS of $6.13 from the previous fiscal year.
4. Looking ahead to the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a low estimate of $6.40 and a high estimate of $7.90. This suggests an increase from the EPS of $6.59 reported for the current fiscal year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
MACD of IMM
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
